Dartmouth-Hitchcock logo
Back
 
NH SafeRx: Ethics and Oversight of Psychotropic Medications for Children in Out-of-Home Placement

This video is a voice-over PowerPoint meant for clinical prescribers who care for youth in NH involved with the child welfare system. William Burl Daviss, MD, and Erin Barnett, PhD, summarize general differences in “rates” of psychotropic medication prescriptions to children in out-of-home placements compared to the general Medicaid population, and describe the NH DCYF policy regarding psychotropic medications. The presenters define “red flag” psychotropic medication scenarios that would trigger DCYF review and describe ways in which NH DCYF caseworkers are mandated to provide oversight around the use of psychotropics (according to policy). In the presentation, viewers will learn how and where to access resources and information on the NH SafeRx web page to help them in providing care, including consent forms for wards of the state, monitoring guidelines, symptom rating scales, and handouts for youth and families. Finally, using case examples, the presenters help clinicians become aware of common ethical dilemmas when caring for children involved with DCYF and provide insights into how to navigate these dilemmas.

Activity Details
Start Date: May 18, 2018
End Date: May 18, 2021
Link: View Presentation
Presenters
  • William “Burl” Daviss, MD, Board-certified Child and Adolescent
    Psychiatrist, Associate Professor of Psychiatry, Academic Chief of Child/Adolescent Psychiatry, Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center
  • Erin Barnett, PhD, Licensed psychologist, Assistant Professor of Psychiatry and The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center
Registration

There is no fee for this activity, but to receive credit(s) you must register online and complete the online evaluation (you must register to access).

Learning Outcome(s)

At the conclusion of this learning activity, participants will be able to discuss the key components of “Safe Rx: DCYF’s Psychotropic Medication Oversight Program” including diagnostic criteria, polypharmacy and use of psychotropics for children in out-of-home placements, need for medication reviews, oversight of children in out-of-home placements, ethical dilemmas, and available resources.

Accreditation

Dartmouth-Hitchcock is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Dartmouth-Hitchcock designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Requirements for Successful Completion

In order to receive credit for this Continuing Medical Education (CME) activity, you must:

  • View the entire presentation
  • Complete the activity evaluation. (you must register to access).
Speaker Disclosure

In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.

The activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for NH SafeRx: Ethics and Oversight of Psychotropic Medications for Children in Out-of-Home Placement have reported NO financial interest or relationship* with various companies. There were no individuals in a position to control the content that refused to disclose.

*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.

Provider Contact Information

Provider contact information for questions regarding accreditation of the activity:
Center for Learning and Professional Development
Dartmouth-Hitchcock Medical Center
clpd.support@hitchcock.org


Type:     Internet Activity (Enduring Material)
15 Registered Users

0